Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.
Lev Facher is an Addiction Reporter at STAT News. He covers a range of topics within health and wellness, focusing on consumer health, mental health, and the emerging fields of cannabis and psychedelic research and therapy. Lev's work has been featured in The Boston Globe, STAT News, and RamaOnHealthcare.















